Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-25 @ 11:53 AM
NCT ID:
NCT01894061
Group ID:
EG000
Title:
Bevacizumab and NovoTTF-100A
Description:
Bevacizumab will be administered intravenously on days 1 and 15 of each 28 day cycle.The dose of bevacizumab will be 10 mg/kg of actual body weight.
Bevacizumab: Bevacizumab will be administered intravenously on days 1 and 15 of each 28 day cycle. The dose of bevacizumab will be 10 mg/kg of actual body weight.
NovoTTF-l00A: NovoTTF-100A will be worn continuously.
Quality of Life Assessment: Functional Assessment of Cancer Therapy including Brain Tumor module (FACT-Br) questionnaire
Deaths Number Affected:
21
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
25
Other Number Affected:
20
Other Number At Risk:
25
Study:
NCT01894061
Results Section:
NCT01894061
Adverse Events Module:
NCT01894061